Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
CD44s used to differentiate between benign and malignant papillary lesions of the breast
December 29th, 2005
CD44s could be used to differentiate between benign and malignant papillary lesions of the breast. According to recent research from the People's Republic of China, "CD44s, the standard form of CD44, has been shown to be downregulated during malignant transformation of breast cancers. It has also been reported recently to be a useful marker in differentiating between benign and malignant papillary lesions of the breast, with high expression in the former." "CD44s expression in benign and malignant papillary lesions was evaluated. CD44s expression was assessed by immunohistochemistry in 101 benign papillomas and 59 papillary carcinomas (7 invasive...
Source: Women's Health Weekly (2005-12-29)
|
